JPMorgan raises Intel to neutral from underweight
INTC•JPMorgan raised its rating on Intel to neutral from underweight.
Related News
GCM Grosvenor cuts target price to $14.50 from $16
GCMG•
JPMorgan raises BioMarin Pharmaceutical target price to $87 from $86
BMRN•
Regions Financial: RBC cuts target price to $32 from $34
RF•
Indian bonds rise after sharp drop in US yields spurs value buying
TLT•
US oil poised to revisit September 15 high of $106.75
USO•